5-Bromo-1-methyl-1H-imidazole(CAS: 1003-21-0)

5-Bromo-1-methyl-1H-imidazole (CAS: 1003-21-0) is classified under GHS as a skin and eye irritant. It is regulated under REACH in the EU and requires registration if used at or above a certain threshold. FDA and EPA have specific reporting and handling requirements for this chemical in the US. Occupational Safety and Health Administration (OSHA) also sets workplace exposure limits for this compound.

While 5-Bromo-1-methyl-1H-imidazole (CAS: 1003-21-0) is commonly used in synthesis, alternatives like 2-bromo-1-methylimidazole and 5-iodo-1-methyl-1H-imidazole can be considered. Other reagents such as bromoethylamine can also be used in similar reactions, offering different functional group possibilities.

The market for 5-Bromo-1-methyl-1H-imidazole (CAS: 1003-21-0) is stable, with increasing demand in pharmaceutical and organic synthesis applications. Research trends are focusing on its use in developing new drugs and as an intermediate in the synthesis of other compounds. The trend towards more sustainable and environmentally friendly processes is also influencing its use.

Waste containing 5-Bromo-1-methyl-1H-imidazole (CAS: 1003-21-0) should be collected in sealed containers and disposed of according to local regulations. Incineration is a common method, but professional waste disposal services are recommended to ensure compliance. Environmental protection precautions include ensuring no spillage and proper labeling of waste containers to prevent accidental exposure.